A patient is starting a cholinesterase inhibitor for early Alzheimer disease. Which statement by a spouse indicates need for further teaching?

• A. This drug significantly slows the progression of the disease.
• B. The drug may modestly improve cognition and may slightly delay progression.
• C. The drug cures Alzheimer disease.
• D. The drug has no side effects.

Answer: (A)

Cholinesterase inhibitors offer modest symptomatic help in early Alzheimer disease by increasing acetylcholine in brain synapses, which can translate into small improvements in memory, attention, and daily function for some patients. They do not cure the disease, and they do not dramatically alter its course. The belief that this drug significantly slows progression over time overstates its effect and signals a need for further teaching. Realistic expectations are that any benefit is modest and variable, while the disease continues to progress. Side effects are common and can include nausea, vomiting, diarrhea, loss of appetite, dizziness, and slower heart rate, so monitoring and patient-specific adjustments are important.